In addition, immunohistochemistry analysis of cancer tissue clinical samples confirmed that TLR3 was highly expressed in the cancer cell nucleus of tumors after neoadjuvant chemotherapy (Fig. 1f, g). Here, TLR3 is linked to cancer.